During the past decade, Lakeshore Infectious Disease Associates CRS conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lakeshore Infectious Disease Associates CRS" #1 collaborator was "Chiron Corporation" with 1 trials as a collaborator and "Community Programs for Clinical Research on AIDS" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Lakeshore Infectious Disease Associates CRS" are "HIV Infections" (4 trials). Many other conditions were trialed in "Lakeshore Infectious Disease Associates CRS" in a lesser frequency.

Most popular intervention types in "Lakeshore Infectious Disease Associates CRS" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Antiretroviral Regimens" (1 trials) and "Recombinant interleukin-2 (rIL-2)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lakeshore Infectious Disease Associates CRS" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Lakeshore Infectious Disease Associates CRS". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Lakeshore Infectious Disease Associates CRS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lakeshore Infectious Disease Associates CRS, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".